Global phosphoproteomic effects of natural tyrosine kinase inhibitor, genistein, on signaling pathways

Proteomics

Volumn 10, Issue 5, 2010, Pages 976-986

  Yan, Guang Rong ^a   Xiao, Chuan Le ^a   He, Gui Wei ^a   Yin, Xing Feng ^a   Chen, Nan Peng ^a   Cao, Ya ^b   He, Qing Yu ^a  

^a JINAN UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

Cell biology; Genistein; Phosphorylation; Signaling pathway; Stable isotope labeling by amino acids in cell culture; Tyrosine kinase

Indexed keywords

ABELSON KINASE; ANTINEOPLASTIC AGENT; EPIDERMAL GROWTH FACTOR RECEPTOR; GENISTEIN; INSULIN RECEPTOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOPROTEIN; PHOSPHOPROTEIN PHOSPHATASE; PHOSPHOTYROSINE; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN KINASE; PROTEIN KINASE B; PROTEIN KINASE FYN; PROTEIN TYROSINE KINASE;

AMINO ACID SEQUENCE; ANTINEOPLASTIC ACTIVITY; ARTICLE; DRUG EFFECT; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETER; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN PHOSPHORYLATION; WESTERN BLOTTING;

AMINO ACID SEQUENCE; CELL LINE, TUMOR; DOWN-REGULATION; G2 PHASE; GENISTEIN; HUMANS; ISOTOPE LABELING; MASS SPECTROMETRY; MITOSIS; MOLECULAR SEQUENCE DATA; PEPTIDES; PHOSPHOPROTEINS; PHOSPHORYLATION; PHOSPHOTYROSINE; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PROTEOMICS; REPRODUCIBILITY OF RESULTS; SIGNAL TRANSDUCTION;

EID: 77649151829     PISSN: 16159853     EISSN: 16159861     Source Type: Journal    
DOI: 10.1002/pmic.200900662     Document Type: Article

References (49)

1. Sebolt-Leopold, J. S., English, J. M., Mechanisms of drug inhibition of signaling molecules. Nature 2006, 441, 457-462.
2. Ghoreschi, K., Laurence, A., O'Shea, J. J., Selectivity and therapeutic inhibition of kinases: to be or not to be? Nat. Immunol. 2009, 10, 356-360.
3. Manning, G., Whyte, D. B., Martinez, R., Hunter, T., Sudarsanam, S., The protein kinase complement of the human genome. Science 2002, 298, 1912-1934.
4. Roberts, P. J., Der, C. J., Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer. Oncogene 2007, 26, 3291-3310.
5. Pawson, T., Protein-tyrosine kinases. Getting down to specifics. Nature 1995, 373, 477-478.
6. Alonso, A., Sasin, J., Bottini, N., Friedberg, I. et al., Protein tyrosine phosphatases in the human genome. Cell 2004, 117, 699-711.
7. Arslan, M. A., Kutuk, O., Basaga, H., Protein kinases as drug targets in cancer. Curr. Cancer Drug Targets 2006, 6, 623-634.
8. Druker, B. J., Tamura, S., Buchdunger, E., Ohno, S. et al., Effects of a selective inhibitor of the Abl tyrosine kinase on the growth of Bcr-Abl positive cells. Nat. Med. 1996, 2, 561-566.
9. Geyer, C. E., Forster, J., Lindquist, D., Chan, S. et al., Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N. Engl. J. Med. 2006, 355, 2733-2743.
10. El Touny, L. H., Banerjee, P. P., Identification of a biphasic role for genistein in the regulation of prostate cancer growth and metastasis. Cancer Res. 2009, 69, 3695-3703.
11. Jamadar-Shroff, V., Papich, M. G., Suter, S. E., Soy-derived isoflavones inhibit the growth of canine lymphoid cell lines. Clin. Cancer Res. 2009, 15, 1269-1276.
12. Peterson, G., Barnes, S., Genistein inhibits both estrogen and growth factor-stimulated proliferation of human breast cancer cells. Cell Growth Differ. 1996, 7, 1345-1351.
13. Banerjee, S., Li, Y., Wang, Z., Sarkar, F. H., Multi-targeted therapy of cancer by genistein. Cancer Lett. 2008, 269, 226-242.
14. Banerjee, S., Zhang, Y., Ali, S., Bhuiyan, M. et al., Molecular evidence for increased antitumor activity of gemcitabine by genistein in vitro and in vivo using an orthotopic model of pancreatic cancer. Cancer Res. 2005, 65, 9064-9072.
15. Kang, N. J., Lee, K. W., Rogozin, E. A., Cho, Y. Y. et al., Equol, a metabolite of the soybean isoflavone daidzein, inhibits neoplastic cell transformation by targeting the MEK/ERK/p90RSK/activator protein-1 pathway. J. Biol. Chem. 2007, 282, 32856-33266.
16. Akiyama, T., Ishida, J., Nakagawa, S., Ogawara, H. et al., Genistein, a specific inhibitor of tyrosine-specific protein kinases. J. Biol. Chem. 1987, 262, 5592-5595.
17. Sakla, M. S., Shenouda, N. S., Ansell, P. J., Macdonald, R. S., Lubahn, D. B., Genistein affects HER2 protein concentration, activation, and promoter regulation in BT-474 human breast cancer cells. Endocrine 2007, 32, 69-78.
18. Wang, J., Eltoum, I. E., Lamartiniere, C. A., Genistein alters growth factor signaling in transgenic prostate model (TRAMP). Mol. Cell Endocrinol. 2004, 219, 171-180.
19. Ding, S. J., Qian, W. J., Smith, R. D., Quantitative proteomic approaches for studying phosphotyrosine signaling. Exp. Rev. Proteomics 2007, 4, 13-23.
20. Blagoev, B., Ong, S. E., Kratchmarova, I., Mann, M., Temporal analysis of phosphotyrosine-dependent signaling networks by quantitative proteomics. Nat. Biotechnol. 2004, 22, 1139-1145.
21. Krüger, M., Kratchmarova, I., Blagoev, B., Tseng, Y. H. et al., Dissection of the insulin signaling pathway via quantitative phosphoproteomics. Proc. Natl. Acad. Sci. USA 2008, 105, 2451-2456.
22. Bose, R., Molina, H., Patterson, A. S., Bitok, J. K. et al., Phosphoproteomic analysis of Her2/neu signaling and inhibition. Proc. Natl. Acad. Sci. USA 2006, 103, 9773-9778.
23. Luo, W., Slebos, R. J., Hill, S., Li, M. et al., Global impact of oncogenic Src on a phosphotyrosine proteome. J. Proteome Res. 2008, 7, 3447-3460.
24. Zhang, G., Fenyö , D., Neubert, T. A., Screening for EphB signaling effectors using SILAC with a linear ion trap-orbitrap mass spectrometer. J. Proteome Res. 2008, 7, 4715-4726.
25. Guha, U., Chaerkady, R., Marimuthu, A., Patterson, A. S. et al., Comparisons of tyrosine phosphorylated proteins in cells expressing lung cancer-specific alleles of EGFR and KRAS. Proc. Natl. Acad. Sci. USA 2008, 105, 14112-14117.
26. Zhang, Y., Wolf-Yadlin, A., Ross, P. L., Pappin, D. J. et al., Time-resolved mass spectrometry of tyrosine phosphorylation sites in the epidermal growth factor receptor signaling network reveals dynamic modules. Mol. Cell. Proteomics 2005, 4, 1240-1250.
27. Yan, G., Luo, W., Lu, Z., Luo, X. et al., Epstein-Barr virus latent membrane protein 1 mediates phosphorylation and nuclear translocation of annexin A2 by activating PKC pathway. Cell Signal. 2007, 19, 341-348.
28. Yan, G., Li, L., Tao, Y., Liu, S. et al., Identification of novel phosphoproteins in signaling pathways triggered by latent membrane protein 1 using functional proteomics technology. Proteomics 2006, 6, 1810-1821.
29. Olsen, J. V., Blagoev, B., Gnad, F., Macek, B. et al., Global, in vivo, and site-specific phosphorylation dynamics in signaling networks. Cell 2006, 127, 635-648.
30. Macek, B.,Mijakovic, I., Olsen, J. V., Gnad, F. et al., The serine/threonine/tyrosine phosphoproteome of the model bacterium Bacillus subtilis. Mol. Cell. Proteomics 2007, 6, 697-707.
31. Nichols, A. M., White, F. M., Manual validation of peptide sequence and sites of tyrosine phosphorylation from MS/MS spectra. Methods Mol. Biol. 2009, 492, 143-160.
32. Amanchy, R., Kalume, D. E., Iwahori, A., Zhong, J., Pandey, A., Phosphoproteome analysis of HeLa cells using stable isotope labeling with amino acids in cell culture (SILAC). J. Proteome Res. 2005, 4, 1661-1671.
33. Kyle, E., Neckers, L., Takimoto, C., Curt, G., Bergan, R., Genistein-induced apoptosis of prostate cancer cells is preceded by a specific decrease in focal adhesion kinase activity. Mol. Pharmacol. 1997, 51, 193-200.
34. Xu, D., Qu, C. K., Protein tyrosine phosphatases in the JAK/STAT pathway. Front. Biosci. 2008, 13, 4925-4932.
35. Lu, W., Gong, D., Bar-Sagi, D., Cole, P. A., Site-specific incorporation of a phosphotyrosine mimetic reveals a role for tyrosine phosphorylation of SHP-2 in cell signaling. Mol. Cell 2000, 8, 759-769.
36. Schlessinger, J., Cell signaling by receptor tyrosine kinases. Cell 2000, 103, 211-225.
37. Li, Y., Sarkar, F. H., Inhibition of nuclear factor kappaB activation in PC3 cells by genistein is mediated via Akt signaling pathway. Clin. Cancer Res. 2002, 8, 2369-2377.
38. Regenbrecht, C. R., Jung, M., Lehrach, H., Adjaye, J., The molecular basis of genistein-induced mitotic arrest and exit of self-renewal in embryonal carcinoma and primary cancer cell lines. Biomed Chromatogr. Med. Genom. 2008, 1, 49.
39. Nateri, A. S., Raivich, G., Gebhardt, C., Da Costa, C. et al., ERK activation causes epilepsy by stimulating NMDA receptor activity. EMBO J. 2007, 26, 4891-4901.
40. Gendron, F. P., Neary, J. T., Theiss, P. M., Sun, G. Y. et al., Mechanisms of P2X7 receptor-mediated ERK1/2 phosphorylation in human astrocytoma cells. Am. J. Physiol. Cell Physiol. 2003, 284, C571-C581.
41. Jacques-Silva, M. C., Rodnight, R., Lenz, G., Liao, Z. et al., P2X7 receptors stimulate AKT phosphorylation in astrocytes. Br. J. Pharmacol. 2004, 141, 1106-1117.
42. Ren, X. R., Ming, G. L., Xie, Y., Hong, Y. et al., Focal adhesion kinase in netrin-1 signaling. Nat. Neurosci. 2004, 7, 1204-1212.
43. Bouchard, V., Harnois, C., Demers, M. J., Thibodeau, S. et al., Integrin/Fak/Src signaling in intestinal epithelial crypt cell survival: integration of complex regulatory mechanisms. Apoptosis 2008, 13, 531-542.
44. Zheng, G., Zhang, W., Zhang, Y., Chen, Y. et al., gamma-Aminobutyric acid (A) (GABA(A)) receptor regulates ERK1/2 phosphorylation in rat hippocampus in high doses of methyl tert-butyl ether (MTBE)-induced impairment of spatial memory. Toxicol. Appl. Pharmacol. 2009, 236, 239-245.
45. Sánchez-Blázquez, P., Rodríguez-Muñoz, M., de la Torre-Madrid, E., Garzón, J., Brain-specific Galphaz interacts with Src tyrosine kinase to regulate Mu-opioid receptor-NMDAR signaling pathway. Cell. Signal. 2009, 21, 1444-1454.
46. Makkonen, H., Jääskeläinen, T., Pitkänen-Arsiola, T., Rytinki, M. et al., Identification of ETS-like transcription factor 4 as a novel androgen receptor target in prostate cancer cells. Oncogene 2008, 27, 4865-4876.
47. Kitagawa, M., Lee, S. H., McCormick, F., Skp2 suppresses p53-dependent apoptosis by inhibiting p300. Mol. Cell 2008, 29, 217-231.
48. Sang, N., Stiehl, D. P., Bohensky, J., Leshchinsky, I. et al., MAPK signaling up-regulates the activity of hypoxia-inducible factors by its effects on p300. J. Biol. Chem. 2003, 278, 14013-14019.
49. Chen, Y. J., Wang, Y. N., Chang, W. C., ERK2-mediated C-terminal serine phosphorylation of p300 is vital to the regulation of epidermal growth factor-induced keratin 16 gene expression. J. Biol. Chem. 2007, 282, 27215-27228.1